Morgan Stanley’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.76M | Buy |
932,406
+61,691
| +7% | +$249K | ﹤0.01% | 4290 |
|
2025
Q1 | $2.38M | Buy |
870,715
+189,712
| +28% | +$518K | ﹤0.01% | 4492 |
|
2024
Q4 | $2.89M | Buy |
681,003
+289,970
| +74% | +$1.23M | ﹤0.01% | 4430 |
|
2024
Q3 | $1.15M | Buy |
391,033
+77,436
| +25% | +$228K | ﹤0.01% | 4974 |
|
2024
Q2 | $1.09M | Sell |
313,597
-13,123
| -4% | -$45.7K | ﹤0.01% | 4905 |
|
2024
Q1 | $931K | Sell |
326,720
-1,542,458
| -83% | -$4.4M | ﹤0.01% | 4985 |
|
2023
Q4 | $6.6M | Buy |
1,869,178
+1,190,980
| +176% | +$4.2M | ﹤0.01% | 4212 |
|
2023
Q3 | $1.76M | Buy |
678,198
+505,888
| +294% | +$1.31M | ﹤0.01% | 4470 |
|
2023
Q2 | $679K | Buy |
172,310
+63,344
| +58% | +$250K | ﹤0.01% | 5055 |
|
2023
Q1 | $368K | Buy |
108,966
+35,414
| +48% | +$120K | ﹤0.01% | 5429 |
|
2022
Q4 | $263K | Buy |
73,552
+13,785
| +23% | +$49.4K | ﹤0.01% | 5555 |
|
2022
Q3 | $239K | Sell |
59,767
-1,330
| -2% | -$5.32K | ﹤0.01% | 5645 |
|
2022
Q2 | $273K | Sell |
61,097
-3,205
| -5% | -$14.3K | ﹤0.01% | 5735 |
|
2022
Q1 | $546K | Buy |
64,302
+3,375
| +6% | +$28.7K | ﹤0.01% | 5352 |
|
2021
Q4 | $538K | Sell |
60,927
-9,937
| -14% | -$87.7K | ﹤0.01% | 5497 |
|
2021
Q3 | $737K | Sell |
70,864
-24,686
| -26% | -$257K | ﹤0.01% | 5260 |
|
2021
Q2 | $1M | Buy |
95,550
+9,892
| +12% | +$104K | ﹤0.01% | 5077 |
|
2021
Q1 | $881K | Sell |
85,658
-40,809
| -32% | -$420K | ﹤0.01% | 4813 |
|
2020
Q4 | $1.4M | Buy |
126,467
+126,293
| +72,582% | +$1.4M | ﹤0.01% | 4445 |
|
2020
Q3 | $2K | Sell |
174
-236
| -58% | -$2.71K | ﹤0.01% | 6557 |
|
2020
Q2 | $4K | Sell |
410
-138
| -25% | -$1.35K | ﹤0.01% | 6329 |
|
2020
Q1 | $5K | Sell |
548
-645
| -54% | -$5.89K | ﹤0.01% | 6191 |
|
2019
Q4 | $12K | Buy |
+1,193
| New | +$12K | ﹤0.01% | 6215 |
|